Materials • Major Chemicals
$61.83 ▼ -0.10
(-0.16%)
MKT CAP: $1.92B • VOL: 302.5K
52W L $55 52W H $84
MTX // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.07B | $2.12B | $2.17B |
| YoY Revenue Growth % | -2.2% | -2.4% | — |
| Gross Profit | $518.0M | $547.7M | — |
| Gross Margin % | 25.0% | 25.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $47.4M | $286.5M | $171.8M |
| Operating Margin % | 2.3% | 13.5% | 7.9% |
| Net Income (GAAP) | -$18.4M | $167.1M | $84.1M |
| EBITDA (Normalized) | $133.1M | $358.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $193.7M | $236.4M | $233.6M |
| Capital Expenditures (CapEx) | $107.1M | $89.5M | — |
| Free Cash Flow (FCF) | $86.6M | $146.9M | $233.6M |
| FCF Margin % | 4.2% | 6.9% | 10.8% |
| Return on Invested Capital (ROIC %) | 1.6% | 9.5% | — |
| Cash & Short-Term Equivalents | $329.0M | $333.1M | — |
| Total Debt (Short + Long Term) | $955.0M | $959.6M | — |
| Total Stockholders' Equity | $1.71B | $1.75B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR MTX.